Acquiring Company
OpenAI
Acquired Company
Orchestra Bio
Description
On October 20, 2026, OpenAI announced its acquisition of Orchestra Bio, a startup building a platform for managing biomedical projects. The technology will be integrated into OpenAI's scientific division, Rosalind. Financial terms of the deal were not disclosed.
Who to call at OpenAI, and when
When OpenAI changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day OpenAI raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OpenAI, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OpenAI makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Orchestra Bio?
Orchestra Bio was acquired by OpenAI. The deal was reported on October 20, 2026. OpenAI is privately held and operates in Artificial Intelligence.
When did OpenAI acquire Orchestra Bio?
OpenAI's acquisition of Orchestra Bio was reported on October 20, 2026. On October 20, 2026, OpenAI announced its acquisition of Orchestra Bio, a startup building a platform for managing biomedical projects. The technology will be integrated into OpenAI's scientific division, Rosalind. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Orchestra Bio do?
Orchestra Bio is a startup founded in 2022 that builds a platform for managing biomedical research projects. Its platform integrates individual research stages into a unified management system with AI agents. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.